Model‐Based Meta‐Analysis in Ankylosing Spondylitis: A Quantitative Comparison of Biologics and Small Targeted Molecules-Reference-Cited by-同舟云学术

Model‐Based Meta‐Analysis in Ankylosing Spondylitis: A Quantitative Comparison of Biologics and Small Targeted Molecules

Published:2019-01-18 Issue:5 Volume:105 Page:1244-1255
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wu Yunjiao¹²,Feng Xinying²,Li Jiapeng¹,Wang Xiaoling¹,Yang Changqing²,Zhao Libo¹

Affiliation:

1. Clinical Research CenterBeijing Children's HospitalCapital Medical UniversityNational Center for Children’s Health Beijing China

2. School of Basic Medicine and Clinical PharmacyChina Pharmaceutical University Nanjing China

Funder

National Science and Technology “creation of major new drugs”

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1305

Reference31 articles.

1. Ankylosing spondylitis

2. Global prevalence of ankylosing spondylitis

3. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

4. Ankylosing Spondylitis and Axial Spondyloarthritis

5. Indirect comparison of anti‐TNF‐alpha agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials;Shu T.;Clin. Exp. Rheumatol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative evaluation of the time-course and efficacy of targeted agents for ulcerative colitis;Frontiers in Pharmacology;2024-06-05

2. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis;Nature Reviews Rheumatology;2023-10-06

3. A Predictive Disease Risk Model for Ankylosing Spondylitis: Based on Integrated Bioinformatic Analysis and Identification of Potential Biomarkers Most Related to Immunity;Mediators of Inflammation;2023-04-27

4. Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease;Frontiers in Immunology;2022-03-17

5. Applications of Model-Based Meta-Analysis in Drug Development;Pharmaceutical Research;2022-02-16